HK1004340A1 - Essentially pure human parathyroid hormone - Google Patents

Essentially pure human parathyroid hormone

Info

Publication number
HK1004340A1
HK1004340A1 HK98103454A HK98103454A HK1004340A1 HK 1004340 A1 HK1004340 A1 HK 1004340A1 HK 98103454 A HK98103454 A HK 98103454A HK 98103454 A HK98103454 A HK 98103454A HK 1004340 A1 HK1004340 A1 HK 1004340A1
Authority
HK
Hong Kong
Prior art keywords
parathyroid hormone
human parathyroid
essentially pure
pure human
ultrapure
Prior art date
Application number
HK98103454A
Other languages
English (en)
Inventor
Dennis R Sindrey
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24840399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1004340(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of HK1004340A1 publication Critical patent/HK1004340A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Glass Compositions (AREA)
HK98103454A 1991-05-23 1998-04-24 Essentially pure human parathyroid hormone HK1004340A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/707,114 US5208041A (en) 1991-05-23 1991-05-23 Essentially pure human parathyroid hormone

Publications (1)

Publication Number Publication Date
HK1004340A1 true HK1004340A1 (en) 1998-11-20

Family

ID=24840399

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103454A HK1004340A1 (en) 1991-05-23 1998-04-24 Essentially pure human parathyroid hormone

Country Status (16)

Country Link
US (1) US5208041A (fi)
EP (1) EP0515228B1 (fi)
JP (1) JP2563726B2 (fi)
KR (1) KR970007755B1 (fi)
AT (1) ATE164394T1 (fi)
CA (1) CA2068438C (fi)
DE (1) DE69224858T2 (fi)
DK (1) DK0515228T3 (fi)
ES (1) ES2115642T3 (fi)
FI (1) FI106802B (fi)
HK (1) HK1004340A1 (fi)
IE (1) IE921672A1 (fi)
IL (3) IL101829A (fi)
NO (2) NO304190B1 (fi)
NZ (1) NZ242855A (fi)
ZA (1) ZA923735B (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
TW273513B (fi) * 1993-10-27 1996-04-01 Chugai Pharmaceutical Co Ltd
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US6300127B1 (en) 1997-07-30 2001-10-09 Emory University Bone mineralization proteins, DNA, vectors, expression systems
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
AR033639A1 (es) 1998-08-19 2004-01-07 Lilly Co Eli Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
JP4486256B2 (ja) * 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
WO2000032771A1 (en) * 1998-11-30 2000-06-08 The General Hospital Corporation Pth1r and pth3r receptors, methods and uses thereof
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
US7087248B2 (en) 2000-06-30 2006-08-08 Daiichi Asubio Pharma Co., Ltd. Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component
US6387711B1 (en) * 2000-08-11 2002-05-14 Quest Diagnostics Investments Incorporated Liquid intact parathyroid hormone (PTH) standards
US6905886B2 (en) * 2000-08-11 2005-06-14 Quest Diagnostics Investments Incorporated Preservative solutions
AU2002339843B2 (en) * 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
JP4334480B2 (ja) * 2003-03-19 2009-09-30 ザ ジェネラル ホスピタル コーポレイション α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
US7910544B2 (en) 2003-07-17 2011-03-22 The General Hospital Corporation Conformationally constrained parthyroid hormone (PTH) analogs
AU2005244734A1 (en) * 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
EP1945245A2 (en) * 2005-11-10 2008-07-23 The Board of Control of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
EP2650009B8 (en) 2007-08-01 2018-07-18 The General Hospital Corporation Screening methods using G-protein coupled receptors and related compositions
RU2441019C2 (ru) * 2007-08-09 2012-01-27 Юсв Лимитед Способ синтеза рекомбинантного паратиреоидного гормона человека
CN102471368A (zh) * 2009-08-11 2012-05-23 拜康有限公司 色谱方法及其纯化的化合物
CA2782640A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
JP5941040B2 (ja) 2010-05-13 2016-06-29 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン類似体およびその使用
KR101787956B1 (ko) * 2011-06-07 2017-10-18 아사히 가세이 파마 가부시키가이샤 고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
LU100168B1 (en) 2017-04-12 2018-10-15 Michael Pazianas Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
EP4110370A4 (en) 2020-03-30 2023-06-07 Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. FORMULATIONS OF HUMAN PARATHYROID HORMONE (PTH) AND METHODS OF MANUFACTURE THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
AU6448990A (en) * 1989-09-29 1991-04-28 Her Majesty in Right of Canada, as represented by National Research Council Canada Synthesis of mature human parathyroid hormone

Also Published As

Publication number Publication date
JPH0687897A (ja) 1994-03-29
KR970007755B1 (en) 1997-05-16
FI922356A (fi) 1992-11-24
DK0515228T3 (da) 1998-09-28
NO2006013I1 (no) 2006-11-06
AU639856B2 (en) 1993-08-05
NO2006013I2 (no) 2009-12-07
FI106802B (fi) 2001-04-12
IL101829A (en) 1999-12-31
CA2068438A1 (en) 1992-11-24
IE921672A1 (en) 1992-12-02
IL119840A (en) 2005-08-31
NO922000D0 (no) 1992-05-21
JP2563726B2 (ja) 1996-12-18
FI922356A0 (fi) 1992-05-22
ES2115642T3 (es) 1998-07-01
ATE164394T1 (de) 1998-04-15
NO304190B1 (no) 1998-11-09
US5208041A (en) 1993-05-04
AU1604992A (en) 1993-03-11
NZ242855A (en) 1994-04-27
CA2068438C (en) 1996-11-12
NO922000L (no) 1992-11-24
DE69224858D1 (de) 1998-04-30
EP0515228B1 (en) 1998-03-25
IL119840A0 (en) 1997-03-18
EP0515228A3 (fi) 1994-05-04
ZA923735B (en) 1993-01-27
IL101829A0 (en) 1992-12-30
DE69224858T2 (de) 1998-07-23
EP0515228A2 (en) 1992-11-25

Similar Documents

Publication Publication Date Title
KR970007755B1 (en) Essential pure human parathyroid hormone
DE69405102D1 (en) Antikoerperfragmente in therapie
HUT44443A (en) Preparation and method for cleaning and disinfecting contact-lenses
IT8221194A0 (it) Procedimento e dispositivo per la deformazione dei corpi di lattine e dispositivo per l'esecuzione di questo procedimento.
ATE72833T1 (de) Rinder-prowachstums- und -wachstumshormon.
DE3680997D1 (de) Einrichtung zur als sprache empfundenen rueckkopplung.
IL97981A0 (en) Method for reducing carryover contamination in an amplification procedure
EP0169532A3 (en) Magnet driving method and device for same
FI864654A (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
EP0168030A3 (en) Contact type image sensor and driving method therefor
EP0181009A3 (en) Image processing device and method for controlling the same
AU577692B2 (en) Lorgnette frame
EP0196405A3 (en) Color picture reader and method for operating the same
GR851623B (fi)
GR3003691T3 (fi)
IT8467198A1 (it) Metodo e dispositivo per il controllo dei processi di saldatura mediante l'analisi della luminosita' generata durante il processo.
HU900822D0 (en) Trichoderma-fungus and fungicid containing it
EP0205726A3 (en) Image controlling method and device for carrying out the same
GB8904194D0 (en) Method for measuring and controlling ozone concentration
EP0127467A3 (en) Self incompatibility glycoprotein
JPS6465184A (en) Method for sealing epoxy fluorinated carbon
GR930300014T1 (en) Burst-test
PL273538A1 (en) Method for controlling operation of current sopurce in a magnetic-powder defectoscope excitation device and a system for controlling the current source of a magnetic-powder defectoscope excitation device
GB8722469D0 (en) Protein assay device & method

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20120521